Ex vivo administration of a retroviral vector carrying IL1RN cDNA to human autologous synovial fibroblasts, followed by their intra-articular injections into the metacarpophalangeal joints, lead to a lower swelling and pain in patients with rheumatoid arthritis [234]. The gene discussed is IL1RN; the disease is rheumatoid arthritis.